Aggarwal S, Gurney AL (2002) IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 71:1–8

Article  CAS  PubMed  Google Scholar 

Aghayev T, Mazitova AM, Fang JR et al (2022) IL27 signaling serves as an immunologic checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma. Cancer Discov 12:1960–1983

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akdis M, Burgler S, Crameri R et al (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127(701–21):e1-70

Google Scholar 

Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1:219–227

Article  CAS  PubMed  Google Scholar 

Ambade A, Satishchandran A, Saha B et al (2016) Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1alphainduced IL-10. Oncoimmunology 5:e1221557

Article  PubMed  PubMed Central  Google Scholar 

Bachem A, Guttler S, Hartung E et al (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207:1273–1281

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastian D, Wu Y, Betts BC et al (2019) The IL-12 cytokine and receptor family in graft-vs.-host disease. Front Immunol 10:988

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batra SA, Rathi P, Guo L et al (2020) Glypican-3-specific CAR T cells coexpressing IL15 and IL21 have superior expansion and antitumor activity against hepatocellular carcinoma. Cancer Immunol Res 8:309–320

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertrand MJ, Milutinovic S, Dickson KM et al (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689–700

Article  CAS  PubMed  Google Scholar 

Boraschi D, Italiani P, Weil S et al (2018) The family of the interleukin-1 receptors. Immunol Rev 281:197–232

Article  CAS  PubMed  Google Scholar 

Brenner D, Blaser H, Mak TW (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15:362–374

Article  CAS  PubMed  Google Scholar 

Catalan-Dibene J, McIntyre LL, Zlotnik A (2018) Interleukin 30 to Interleukin 40. J Interferon Cytokine Res 38:423–439

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen IX, Chauhan VP, Posada J et al (2019a) Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc Natl Acad Sci U S A 116:4558–4566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen EB, Zhou ZJ, Xiao K et al (2019b) The miR-561-5p/CX(3)CL1 signaling axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX(3)CR1(+) natural killer cells infiltration. Theranostics 9:4779–4794

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Shuangyan T, Shi F et al (2024) TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study. Front Immunol 15:1430571

Article  PubMed  PubMed Central  Google Scholar 

Chen Z, Zhang G, Ren X et al (2023) Crosstalk between myeloid and B cells shapes the distinct microenvironments of primary and secondary liver cancer. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-23-0193

Cho Y, Cho EJ, Lee JH et al (2016) Hypoxia enhances tumor-stroma crosstalk that drives the progression of hepatocellular carcinoma. Dig Dis Sci 61:2568–2577

Article  CAS  PubMed  Google Scholar 

Clark DN, Begg LR, Filiano AJ (2022) Unique aspects of IFN-gamma/STAT1 signaling in neurons. Immunol Rev 311:187–204

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui C, Fu K, Yang L et al (2019) Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway. J Exp Clin Cancer Res 38:229

Article  PubMed  PubMed Central  Google Scholar 

Damdinsuren B, Nagano H, Wada H et al (2007) Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells. Int J Oncol 30:201–208

CAS  PubMed  Google Scholar 

Dang Y, Chen J, Feng W et al (2020) Interleukin 1beta-mediated HOXC10 overexpression promotes hepatocellular carcinoma metastasis by upregulating PDPK1 and VASP. Theranostics 10:3833–3848

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng H, Kan A, Lyu N et al (2020) Dual vascular endothelial growth factor receptor and fibroblast growth factor receptor inhibition elicits antitumor immunity and enhances programmed cell death-1 checkpoint blockade in hepatocellular carcinoma. Liver Cancer 9:338–357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dostert C, Grusdat M, Letellier E et al (2019) The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev 99:115–160

Article  CAS  PubMed  Google Scholar 

Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

Article  CAS  PubMed  Google Scholar 

Finn RS, Ikeda M, Zhu AX et al (2020) Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. J Clin Oncol 38:2960–2970

Article  PubMed  PubMed Central  Google Scholar 

Fox JC, Nakayama T, Tyler RC et al (2015) Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. Cytokine 71:302–311

Article  CAS  PubMed  Google Scholar 

Fredriksson L, Li H, Eriksson U (2004) The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15:197–204

Article  CAS  PubMed  Google Scholar 

Garcia-Irigoyen O, Latasa MU, Carotti S et al (2015) Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis. Hepatology 62:166–178

Article  CAS  PubMed  Google Scholar 

Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39:1003–1018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannelli G, Koudelkova P, Dituri F et al (2016) Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol 65:798–808

Article  CAS  PubMed  Google Scholar 

Grech AP, Gardam S, Chan T et al (2005) Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site. J Biol Chem 280:31572–31581

Article  CAS  PubMed